Back

Safety and effectiveness of dabigatran relative to warfarin in routine care: final results from a long-term monitoring program

25 August 2018 (12:35 - 13:25)
Organised by:
Congress Presentation Part of: Atrial fibrillation, stroke and cardiovascular risk Big Data Analysis ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Kristina Zint

Ingelheim (Germany)

6 More presentations in this session

Presentation thumbnail
Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
Mrs R. Hamershock (Boston, US)
Abstract Slides
Presentation thumbnail
Use of machine learning to determine stroke severity of patients diagnosed with stroke in claims data
Doctor E. Kogan (Raritan, US)
Abstract
Presentation thumbnail
National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF from CPRD linked database: does 'big data' reflect clinical trials and identify areas for improvement?
Doctor V. Mehta (London, GB)
Abstract Slides
Presentation thumbnail
Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database
Doctor H. Yokoi (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations
Doctor R. Rosenson (New York City, US)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation, stroke and cardiovascular risk

The Event

Event poster

ESC Congress 2018

25 August 2018 12:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources